US 7,521,540 B2
	CYR61 compositions and methods
Lester F. Lau, Chicago, Ill. (US); Cho-Yau Yeung, Oak Park, Ill. (US); and Jeffrey A. Greenspan, Chicago, Ill. (US)
Assigned to Munin Corporation, Chicago, Ill. (US)
Appl. No. 10/182,432 PCT Filed Jan. 31, 2001, PCT No. PCT/US01/03267 § 371(c)(1), (2), (4) Date Oct. 16, 2002, PCT Pub. No. WO01/55210, PCT Pub. Date Aug. 02, 2001.
Application 10/182432 is a continuation in part of application No. 09/495448, filed on Jan. 31, 2001, granted, now 6,790,606.
Application 09/495448 is a continuation in part of application No. 09/142569, previously published as PCT/US97/04193, filed on Mar. 14, 1997.
Claims priority of provisional application 60/013958, filed on Mar. 15, 1996.
Prior Publication US 2004/0002124 A1, Jan. 01, 2004
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 16/00 (2006.01)

U.S. Cl. 530—387.1

6 Claims

1. An isolated monoclonal antibody that specifically binds to human Cyr61, wherein the antibody binds to amino acids 163-229 of SEQ ID NO:4.